ROLE OF IgG4 IN THE DEVELOPMENT OF CERTAIN AUTOIMMUNE DISEASES
Vol 68 No 3 (2025), Articles
Vol 68 No 3 (2025)

ROLE OF IgG4 IN THE DEVELOPMENT OF CERTAIN AUTOIMMUNE DISEASES

Articles
https://doi.org/10.33149/vkp.2025.03.03
Published August 10, 2025
Y. M. Teleki
Bukovinian State Medical University
L. M. Honcharuk
Bukovinian State Medical University
O. Yu. Olinyk
Bukovinian State Medical University
Yu. V. Kokhanyuk
Bukovinian State Medical University
PDF (Українська)

Keywords

IgG4-related diseases, rheumatoid arthritis, Sjögren's syndrome, autoimmune pancreatitis, pathogenesis, diagnostics.

How to Cite

Teleki, Y. M., Honcharuk, L. M., Olinyk, O. Y., & Kokhanyuk, Y. V. (2025). ROLE OF IgG4 IN THE DEVELOPMENT OF CERTAIN AUTOIMMUNE DISEASES. Herald of Pancreatic Club, 68(3), 20-24. https://doi.org/10.33149/vkp.2025.03.03
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract views: 299
PDF Downloads: 141

Abstract

This article analyzes the role of immunoglobulin G4 (IgG4) in the development of certain autoimmune diseases. The authors present IgG4 as a unique subclass of immunoglobulins characterized by anti-inflammatory and immunomodulatory properties. It has been demonstrated that an imbalance between IgG4 and other classes or subclasses of immunoglobulins can lead to various consequences, tilting the clinical picture towards suppression of inflammation or its activation. IgG4-related diseases form an ever-growing group of fibroinflammatory diseases with specific clinical features: pseudotumours, storiform fibrosis, and obliterative phlebitis. The article provides a detailed description of the pathogenesis of IgG4-associated diseases, including autoimmune pancreatitis, Sjögren's syndrome, systemic lupus erythematosus, and rheumatoid arthritis.

IgG4-related diseases represent a group of fibroinflammatory conditions characterized by plasma cell infiltration and storiform fibrosis. Particular attention is given to the mechanisms of B-cell activation, which produce profibrotic molecules, and the role of IgG4 in promoting fibrosis and inflammation. The authors note that elevated serum IgG4 levels do not always correlate with clinical disease activity. The article discusses modern diagnostic criteria for IgG4-related diseases, including histopathological and radiological signs, as well as exclusion criteria. Recent research findings are presented, highlighting new biomarkers for diagnosing and monitoring these diseases.

The role of IgG4 in rheumatological practice, particularly in rheumatoid arthritis, is also examined. The authors emphasize that IgG4 may serve as a promising biomarker for disease activity and treatment efficacy. The article underscores the need for further research to deepen the understanding of IgG4 mechanisms and its role in the development of autoimmune and rheumatic diseases.

https://doi.org/10.33149/vkp.2025.03.03
PDF (Українська)

References

1. Губергріц Н. Б. Коментарі до Європейських рекомендацій щодо IgG4-асоційованих гастроентерологічних захворювань. Вісник клубу панкреатологів. 2023; 2: 39–43. https://doi.org/10.33149/vkp.2023.02.07
2. Рекалов Д. Г., Данюк ІО. Клінічний випадок IgG4-асоційованого ураження органів дихання та вибір оптимальної лікувальної стратегії. Український ревматологічний журнал. 2019; 78(4): 37–42. https://doi.org/10.32471/rheumatology.2707-6970.78.12994.
3. Христич Т. М., Телекі Я. М., Гонцарюк Д. О та ін. Хронічний панкреатит: клінічно-патогенетичні особливості розвитку поєднання деяких захворювань та методи медикаментозної корекції. Чернівці; 2022. 584 c.
4. Яременко О. Б., Коляденко Д. І., Петелицька Л. Б. IgG4-залежне захворювання: сучасний стан проблеми й опис клінічного випадку. Український ревматологічний журнал. 2019; 1: 10–19. https://nbuv.gov.ua/UJRN/Urj_2019_1_3.
5. Chakraborty R. K., Aeddula N. R. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) [Updated 2024 Sep. 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2025. https://www.ncbi.nlm.nih.gov/books/NBK537099/.
6. Della-Torre E., Rigamonti E., Perugino C. et al. B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. J Allergy Clin Immunol. 2020; 145(3): 968–981.e14. https://doi.org/10.1016/j.jaci.2019.07.004.
7. Deshpande V., Zen Y., Chan J. et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012; 25: 1181–92. https://doi.org/10.1038/modpathol.2012.72.
8. Engelsgjerd J. S., Leslie S. W., LaGrange C. A. Retroperitoneal fibrosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. PMID: 29494016.
9. Hamano H., Kawa S., Horiuchi A. et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. NEJM. 2001; 344(10): 732–738. https://doi.org/10.1056/ nejm200103083441005.
10. Kamiński B., Błochowiak K. Mikulicz's disease and Küttner's tumor as manifestations of IgG4-related diseases: a review of the literature. Reumatologia. 2020; 58: 243–50. https://doi.org/10.5114/reum.2020.98437.
11. Karim A. F., Eurelings L. E., Bansie R. D. et al. Soluble interleukin-2 receptor: a potential marker for monitoring disease activity in IgG4-related disease. Mediators Inflamm. 2018: 1–6. https://doi.org/10.1155/2018/6103064.
12. Lanzillotta M., Vujasinovic M., Löhr J. M. et al. Update on autoimmune pancreatitis and IgG4-related disease. United European Gastroenterol J. 2025; 13(1): 107–115. https://doi.org/10.1002/ueg2.12738.
13. Maslinska M., Dmowska-Chalaba J., Jakubaszek M. The role of IgG4 in autoimmunity and rheumatic diseases. Front Immunol. 2022; 12: 787422. https://doi.org/10.3389/fimmu.2021.787422.
14. Maslinska M., Kostyra-Grabczak K. Immunoglobulin G4 in primary Sjögren's syndrome and IgG4-related disease — connections and dissimilarities. Front Immunol. 2024; 15: 1376723. https://doi.org/10.3389/fimmu.2024.1376723.
15. Rispens T., Huijbers M. G. The unique properties of IgG4 and its roles in health and disease. Nat Rev Immunol. 2023; 23: 763–78. https://doi.org/10.1038/s41577-023-00871-z.
16. Sakthiswary R., Shaharir S. S., Wahab A. A. Frequency and clinical significance of elevated IgG4 in rheumatoid arthritis: a systematic review. Biomedicines. 2022; 10(3): 558. https://doi.org/10.3390/biomedicines10030558.
17. Shiokawa M., Kodama Y., Sekiguchi K. et al. Laminin 511 is a target antigen in autoimmune pancreatitis. Sci Transl Med. 2018; 10(453): eaaq0997. https://doi.org/10.1126/scitranslmed.aaq0997.
18. Tang H., Yang H., Zhang P. et al. Malignancy and IgG4-related disease: the incidence, related factors and prognosis from a prospective cohort study in China. Sci Rep. 2020; 10(1): 4910. https://doi.org/10.1038/s41598-020-61585-z.
19. Trampert D. C., Hubers L. M., van de Graaf S. et al. On the role of IgG4 in inflammatory conditions: lessons for IgG4-related disease. Biochim Biophys Acta Mol Basis Dis. 2018; 1864(4 Pt B): 1401–1409. https://doi.org/10.1016/j.bbadis. 2017.07.038.
20. Trypilka S., Yehudina Y. A clinical case of the retroperitoneal fibrosis (Ormond’s disease) in rheumatology practice. PAIN, JOINTS, SPINE. 2021; 11(1): 42–49. https://doi.org/10.22141/2224-1507.11.1.2021.226909.
21. Turner J. D., Faulkner H., Kamgno J. et al. Allergen-specific IgE and IgG4 are markers of resistance and susceptibility in a human intestinal nematode infection. Microbes Infect. 2005; 7(7–8): 990–6. https://doi.org/10.1016/j.micinf.2005.03.036.
22. Wallace Z. S., Naden R. P., Chari S. et al. The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. Arthritis Rheumatol. 2020; 72(1): 7–19. https://doi.org/10.1002/art.41120.